Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aerovironment, Inc., (“Aerovironment" or the "Company") (NASDAQ: AVAV) investors that the firm has initiated an...
-
Portnoy Law Firm Announces Class Action on Behalf of Regencell Bioscience Holdings Limited Investors
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regencell Bioscience Holdings Limited, (“Regencell” or the "Company") (NASDAQ: RGC) investors of a class action on behalf...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Gemini Space Station, Inc., (“Gemini” or the "Company") (NASDAQ:GEMI) investors of a class action on behalf of investors...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises SNDL, Inc., (“SNDL" or the "Company") (NASDAQ: SNDL) investors that the firm has initiated an investigation into possible...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Gossamer Bio, Inc., (“Gossamer” or the "Company") (NASDAQ: GOSS) investors of a class action on behalf of investors that...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Lufax Holding, Ltd., (“Lufax” or the "Company") (NYSE: LU) investors of a class action on behalf of investors that bought...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hercules Capital, Inc., (“Hercules” or the "Company") (NYSE: HTGC) investors of a class action on behalf of investors...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Super Micro Computer, Inc., (“Super Micro” or the "Company") (NASDAQ: SMCI) investors of a class action on behalf of...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Coty, Inc., (“COTY” or the "Company") (NYSE: COTY) investors of a class action on behalf of investors that bought...
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aldeyra Therapeutics, Inc., (“Aldeyra” or the "Company") (NASDAQ: ALDX) investors of a class action on behalf of...